Phase 1 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have breast cancer that cannot be surgically removed and has either spread to nearby areas or to other parts of the body
- People whose breast cancer has been confirmed by a tissue or cell sample showing a specific protein called HER2 at high levels (tested within the last 2 years), meeting one of two specific measurement thresholds (confirm with trial site)
- People who have at least one tumour that is 15mm or larger in size
- People who are reasonably able to carry out daily activities, rated on a standard medical scale as a 2 or below out of 4 (confirm with trial site)
For Part A of the trial only:
- People who are currently receiving, or are about to start, a standard anti-cancer treatment
For Part B of the trial only:
- People whose cancer has been confirmed by scans to have gotten worse within the last three months
- People who have already received at least 3 different lines of standard anti-cancer treatment for advanced disease
- People who have finished their most recent anti-cancer treatment and whose side effects from that treatment have mostly resolved (confirm with trial site)
Who may not be able to join:
- People who have active cancer spread to the brain
- People who have recently received another experimental treatment drug within a certain time window before the trial (confirm with trial site for exact timeframes)
- People who have received any anti-cancer treatment, including radiation therapy within the last 7 days, since their most recent documented cancer progression
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 46859883800
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Treatment emergent adverse events; Dose Limiting Toxicities
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.